Richard Bartram
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Financial Officer | $411,667 | $3,323,282 |
| 2020 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Financial Officer | $400,000 | $2,461,581 |
| 2019 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Financial Officer | $340,000 | $485,500 |
| 2018 | Esperion Therapeutics, Inc. (ESPR) | Chief Financial Officer | $330,000 | $2,539,923 |
Earnings-call appearances
-
Esperion Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-04
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q4 FY2020 Earnings Call2021-02-23
Esperion Therapeutics, Inc. (ESPR)